Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Glossaries
    • About this website
    • Data protection and privacy
    • FAQs
    • Contacts

COVID-19

All info here

QUICK LINKS

  • Latest updates
  • Vaccines
  • Treatments
  • Guidance for developers and companies
  • CHMP highlights: May 2023
    CHMP slider image
    MEDICINES |COMMITTEES

    CHMP highlights: May 2023

  • CHMP highlights: May 2023
    CHMP slider image
    MEDICINES |COMMITTEES

    CHMP highlights: May 2023

    EMA's human medicines committee (CHMP) recommended 2 new medicines for approval in the EU at its May 2023 meeting

  • Industry guidance to prevent medicine shortages
    Guidance |Shortages

    Industry guidance to prevent medicine shortages

  • Industry guidance to prevent medicine shortages
    Guidance |Shortages

    Industry guidance to prevent medicine shortages

    EMA has published recommendations for marketing authorisation holders, wholesalers, distributors and manufacturers to prevent human medicine shortages and reduce their impact.

  • 2022 annual report published
    Slider image for EMA 2022 annual report
    EMA |About us

    2022 annual report published

  • 2022 annual report published
    Slider image for EMA 2022 annual report
    EMA |About us

    2022 annual report published

    EMA has published its 2022 annual report that provides an overview of the Agency’s major achievements, key figures and contributions to public and animal health in Europe

  • End of COVID-19 public health emergency
    Executive director of EMA
    COVID-19 |Statement

    End of COVID-19 public health emergency

  • End of COVID-19 public health emergency
    Executive director of EMA
    COVID-19 |Statement

    End of COVID-19 public health emergency

    EMA's Executive Director, Emer Cooke, issues a statement after the end of the Public Health Emergency of International Concern (PHEIC) for COVID-19 was declared by the WHO.

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    26/05/2023

    EMA business hours over Whit Monday, 29 May

    The European Medicines Agency's (EMA) office is closed on Monday 29 May 2023. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please note that this is an emergency number...

  • List item
    26/05/2023

    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023

    Two new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended two medicines for approval at its May 2023 meeting. The committee recommended granting a marketing authorisation for Pylclari (piflufolastat (18F)),...

  • List item
    22/05/2023

    Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 2023

    CVMP opinions on veterinary medicinal products Under Regulation (EU) 2019/6 The Committee adopted by consensus a positive opinion for a marketing authorisation application for Eluracat ( capromorelin tartrate ), from Elanco GmbH, a new product for...

  • List item
    17/05/2023

    Guidance for industry to prevent and mitigate medicine shortages

    EMA has published recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact . Medicine shortages are a global health problem and are increasingly affecting...

  • List item
    16/05/2023

    EMA business hours over Ascension Day holidays, 18 and 19 May

    The European Medicines Agency's (EMA) office is closed from 18:30 on Wednesday 17 May until 07:30 on Monday 22 May. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please...

  • List item
    15/05/2023

    EMA annual report 2022 published

    EMA published its annual report 2022 today. The report provides an overview of the Agency’s activities to protect and promote public and animal health in the European Union (EU). The digital report outlines the most important highlights regarding...

  • Load more news

Information for you

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Clinical Trials website

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EudraVigilance Veterinary

  • List item

    Veterinary Medicines information website

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
  • About us
  • What we do
  • Careers
  • Committees
  • Regulatory network
  • Languages
  • Frequently asked questions
  • Glossaries
  • About this website
  • Privacy
  • Search tips
  • Access to documents
  • Contacts
  • Send a question
  • EMA Service desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2023 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag